Genetics of Lung Cancer: Current Thinking on Genetic Predisposition to the Disease and Response to Treatment

作者: Tim Benepal , Athena Matakidou , Ying Zee , Richard Houlston , Tim Eisen

DOI: 10.1007/3-540-31040-1_5

关键词:

摘要:

参考文章(85)
W. E. Gye, W. J. Purdy, The cause of cancer Cassell. ,(1931)
Jim R Woodburn, Susan E Ashton, Simon P Guy, Keith H Gibson, Brenda J Curry, Andrew J Barker, Alan E Wakeling, ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Research. ,vol. 62, pp. 5749- 5754 ,(2002)
Leah N. Klapper, Mark H. Kirschbaum, Michael Seta, Yosef Yarden, Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors Advances in Cancer Research. ,vol. 77, pp. 25- 79 ,(1999) , 10.1016/S0065-230X(08)60784-8
Malcolm R. Alison, The Cancer Handbook ,(2018)
Mark G. Kris, Howard I. Scher, Vincent A. Miller, Maureen F. Zakowski, Francis M. Sirotnak, Efficacy of Cytotoxic Agents against Human Tumor Xenografts Is Markedly Enhanced By Coadministration of ZD1839 (Iressa), an Inhibitor of EGFR Tyrosine Kinase Clinical Cancer Research. ,vol. 6, pp. 4885- 4892 ,(2000)
Margaret R. Spitz, Qingyi Wei, Lie Cheng, Waun Ki Hong, Reduced DNA Repair Capacity in Lung Cancer Patients Cancer Research. ,vol. 56, pp. 4103- 4107 ,(1996)
Neil E. Caporaso, William F. Page, M. Miles Braun, Robert N. Hoover, A cohort study of twins and cancer. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 4, pp. 469- 473 ,(1995)